Kenyan Health Patient Information Leaflet
Proton pump inhibitor (PPI)
Duodenal ulcers, benign gastric ulcers, and prevention of peptic ulcers associated with NSAIDs, reflux oesophagitis, Zollinger-Ellison syndrome Clinical selection for Ilaprazole should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Proton pump inhibitor (PPI). Confirm site-specific dose, duration and monitoring before prescribing.
Dosing is indication-, age-, weight- and organ-function-specific for this INN. Do not use class averages for high-risk patients. Confirm the exact regimen in the current SmPC and Kenya Standard Treatment Guidelines. Typical professional workflow: (1) confirm indication, (2) check renal/hepatic function, (3) screen interactions/allergies, (4) select dose/route/duration, (5) define monitoring.
Candidiasis, GI disturbances, skin rashes, photosensitivity, stomatitis blood dyscrasia, hypersensitivity, CNS effects, paraesthesia, malaise, alopecia, muscle weakness, myalgia, peripheral edema, gynecomastia, hepatitis.
Store as labelled. Keep out of reach of children.